Search

Your search keyword '"COVID-19 pathology"' showing total 145 results

Search Constraints

Start Over You searched for: Descriptor "COVID-19 pathology" Remove constraint Descriptor: "COVID-19 pathology" Journal journal of medical virology Remove constraint Journal: journal of medical virology
145 results on '"COVID-19 pathology"'

Search Results

1. Characterization of the Pathogenic Features of Multiple SARS-CoV-2 Pandemic Strains in Different Mouse Models.

2. Attenuated replication and damaging effects of SARS-CoV-2 Omicron variants in an intestinal epithelial barrier model.

3. Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10.

4. SARS-CoV-2 induces blood-brain barrier and choroid plexus barrier impairments and vascular inflammation in mice.

5. Clinical and pathological features of omicron variant of SARS-CoV-2-associated kidney injury.

6. Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.

7. Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.

8. SARS-CoV-2 infection of kidney tissues in some severe and fatal cases of COVID-19.

9. "Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity".

10. SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients.

11. A study on the morbid histopathological changes in COVID-19 patients with or without comorbidities using minimally invasive tissue sampling.

12. Persistence of neutrophil extracellular traps and anticardiolipin auto-antibodies in post-acute phase COVID-19 patients.

13. Association between emphysema and other pulmonary computed tomography patterns in COVID-19 pneumonia.

14. COVID-19 immunopathology: From acute diseases to chronic sequelae.

15. Establishing reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research.

16. A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.

17. Follow-up CT of "reversed halo sign" in SARS-CoV-2 delta VOC pneumonia: A report of two cases.

18. Severe neonatal COVID-19: Challenges in management and therapeutic approach.

19. Guillain-Barré syndrome is immunogenic in SARS-CoV-2 infected.

21. Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States.

22. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: A prospective observational study.

23. Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry.

24. Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave versus the second wave.

25. Autoimmune complications of COVID-19.

26. Elevated inflammatory markers are associated with poor outcomes in COVID-19 patients treated with remdesivir.

27. Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19.

28. Correlation between a quantitative anti-SARS-CoV-2 IgG ELISA and neutralization activity.

29. Atypical bacterial co-infections among patients with COVID-19: A study from India.

30. Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.

31. Development and validation of a simplified risk score for the prediction of critical COVID-19 illness in newly diagnosed patients.

32. Evaluation of predictors of severe-moderate COVID-19 infections at children: A review of 292 children.

33. Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.

34. Post-COVID syndrome: A single-center questionnaire study on 1007 participants recovered from COVID-19.

35. SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response.

36. Comparison of clinical and biochemical features of hospitalized COVID-19 and influenza pneumonia patients.

39. Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.

40. Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.

42. Prolonged symptom onset to admission time is associated with severe Coronavirus disease: A meta combined propensity-adjusted analysis.

43. Updated SARS-CoV-2 single nucleotide variants and mortality association.

44. Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon, France.

45. COVID-19 sniffer dog experimental training: Which protocol and which implications for reliable sidentification?

46. Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: An in silico approach.

47. Cytokine storm in severe COVID-19 pneumonia.

48. Treatment patterns in US patients hospitalized with COVID-19 and pulmonary involvement.

49. SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.

50. Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.

Catalog

Books, media, physical & digital resources